The emergence of antibiotic resistance in bacteria has severe medical consequences. The goal of the proposed work is to evaluate the use of catalytic antibodies for blocking cell wall biosynthesis in vancomycin resistant bacteria. These resistant bacteria synthesize a modified cell wall substrate with a terminal D-ala-D-lac. This proposal outlines a strategy to construct a phage displayed library of scFv antibodies and then select specific antibodies that catalyze the cleavage the ester linkage of D-ala-D-lac. These antibodies will be tested for their ability to block cell wall biosynthesis using a standard microdilution broth assay. In addition, antibodies which bind D-ala-D-lac will also be selected from the phage library and tested in the microdilution broth assay. Comparison of the two types of antibodies should be useful in evaluating the advantages of catalysis versus binding for inhibiting biochemical processes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32AI010419-03
Application #
6372912
Study Section
Bio-Organic and Natural Products Chemistry Study Section (BNP)
Program Officer
Ikeda, Richard A
Project Start
2001-06-28
Project End
Budget Start
2001-06-28
Budget End
2002-06-27
Support Year
3
Fiscal Year
2001
Total Cost
$40,196
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Zhang, Zhiwen; Gildersleeve, Jeff; Yang, Yu-Ying et al. (2004) A new strategy for the synthesis of glycoproteins. Science 303:371-3
Gildersleeve, Jeff; Varvak, Alex; Atwell, Shane et al. (2003) Development of a high-throughput screen for protein catalysts: application to the directed evolution of antibody aldolases. Angew Chem Int Ed Engl 42:5971-3
Gildersleeve, Jeff; Janes, Jeff; Ulrich, Helle et al. (2002) Development of a genetic selection for catalytic antibodies. Bioorg Med Chem Lett 12:1691-4